Skip to main content
Premium Trial:

Request an Annual Quote

SYN X Lures New Proteomics Pick


Be careful whom you send out for customer service. Brad Thatcher, formerly at California-based Ciphergen Biosystems, placed an instrument at SYN X Pharma in Toronto a little more than a year ago. After continued work with the customer resulting in “very exciting data,” Thatcher finally went back to SYN X — and stayed.

“There was a lot of room for exploration and growth,” says SYN X’s new vice president of proteomics discovery. The company gave Thatcher the chance to “use all the proteomics knowledge I had, rather than just the small corner of it that Ciphergen concentrated on.”

Thatcher, a native Canadian who was lured to the US by higher salaries, got his start in the field about 11 years ago. “It was at that time called protein chemistry and done by people in basement labs,” he recalls.

Now, he focuses on Syndrome X, which includes symptoms of hypertension, renal failure, diabetes, and stroke, among others. “My job is to take apart sera and affected tissues and find out what is changing in them at the protein level, and what pathways are affected.”

The goal is to discover markers that differentiate the stages of a disease and enable better patient classification and treatment.

Meanwhile, Thatcher is accomplishing some personal goals. Three weeks after heading to Toronto, he found an apartment. “I have shelter now,” he says gleefully, “which is a big step from yesterday.”

— Meredith Salisbury

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.